Drug intelligence / Profile preview

scoparone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Scoparone (6,7-dimethoxycoumarin) is a natural bioactive coumarin derivative primarily isolated from the stems and leaves of *Artemisia capillaris*. It exhibits a broad spectrum of pharmacological activities, including anti-inflammatory, anti-oxidant, anti-tumor, lipid-lowering, and anti-coagulant effects. In oncology research, particularly concerning breast cancer, scoparone has been shown to inhibit cell viability and migration while promoting apoptosis. Its mechanism of action involves the suppression of the NF-κB signaling pathway, which is achieved through the regulation of the SNHG12/miR-140-3p/TRAF2 axis. Specifically, scoparone inhibits the expression of the long non-coding RNA SNHG12, leading to the upregulation of miR-140-3p and the subsequent downregulation of TRAF2. Historically, scoparone has also been recognized for its hypotensive and cholagogic (bile-promoting) properties.

Other names
6,7-dimethoxycoumarinesculetin dimethyl ether6,7-dimethoxy-2H-chromen-2-one6,7-dimethoxychromen-2-one
02

Targets

SNHG12TRAF2

Beyond the preview

Go deeper on scoparone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on scoparone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call